Back to Results
First PageMeta Content
Serotonin-norepinephrine reuptake inhibitors / Research / Amines / Cyclopropanes / Milnacipran / European Medicines Agency / Electronic patient-reported outcome / Antidepressant / Fibromyalgia / Chemistry / Clinical research / Health


European Medicines Agency Evaluation of Medicines for Human Use
Add to Reading List

Document Date: 2013-07-21 06:02:35

Open Document

File Size: 607,53 KB

Share Result on Facebook

City

London / /

Company

CHMP Scientific Advisory Group / /

/

Facility

Canary Wharf / /

/

IndustryTerm

food effect / treatment of Fibromyalgia syndrome / defined products / manufacturing overages / pharmaceutical and biological aspects / pharmaceutical development / pharmaceutical excipients / chosen manufacturing process / medicinal product / food contact requirements / Physical and chemical characteristics / treatment of fibromyalgia / a disorder / degradation products / drug products / manufacturing process / /

MedicalCondition

blisters / convulsions / aluminum blister / disease / fibromyalgia / chronic pain / Fibromyalgia syndrome / chronic musculoskeletal pain / pain / fatigue / disorder / chronic pain models / PVC/ACLAR/Al blisters / sleep disorders / chronic rheumatological disorder / /

MedicalTreatment

intravenous infusion / /

Organization

European Medicines Agency / European Union / /

Person

Gonzalo Calvo / Ian Hudson / Pierre Fabre / Pierre Fabre Médicament / Martin Votava / /

/

Product

talc / epinephrine / /

ProgrammingLanguage

EC / C / /

ProvinceOrState

Nebraska / /

Technology

X-ray / API / pharmacodynamics / process control / /

URL

http /

SocialTag